Inhibitors targeting USP52, or ubiquitin-specific protease 52, would be a class of chemicals that modulate the activity of this deubiquitinating enzyme. By altering the ubiquitination status of proteins, these inhibitors can affect the stability, localization, and function of proteins involved in various cellular processes, leading to changes in cell cycle progression, DNA repair mechanisms, and signal transduction pathways. USP52 inhibitors can act directly by binding to the active site of the enzyme or indirectly by affecting its expression, substrate availability, or interactions with other cellular components.
USP52 inhibitors can vary widely, depending on the mechanism by which they exert their modulatory effects. Some inhibitors may mimic substrate proteins, competitively binding to the USP52 active site. Others may bind allosterically, changing the enzyme's conformation and thus its activity. Additionally, some chemicals might influence the expression levels of USP52 by affecting transcription factors or signaling pathways responsible for the gene's expression. Furthermore, molecules that hinder the interaction between USP52 and its regulatory proteins or substrates can also serve as functional inhibitors, even if they do not directly bind to the enzyme itself. Each inhibitor's specific chemical structure and mode of action dictate its place within the broader category of USP52 inhibitors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can stabilize protein levels, indirectly affecting ubiquitin-related processes. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
A NEDD8-activating enzyme inhibitor that can disrupt the neddylation pathway, which indirectly affects ubiquitination. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
A USP14 inhibitor that can alter deubiquitinating activity, potentially influencing USP52 indirectly. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $77.00 $188.00 $431.00 | 1 | |
A broad-spectrum DUB inhibitor that may impact USP52 by generally inhibiting deubiquitinating activities. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An inhibitor of ubiquitin-activating enzyme E1, indirectly affecting ubiquitin-dependent processes including USP52. | ||||||
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $204.00 | 1 | |
A USP4 inhibitor that may disturb related DUB activities, potentially impacting USP52 indirectly. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
An inhibitor of USP2, which could indirectly affect the balance of ubiquitination and impact USP52. | ||||||
Stat3 Inhibitor III, WP1066 | 857064-38-1 | sc-203282 | 10 mg | $132.00 | 72 | |
A deubiquitinase inhibitor with broad action that may alter the activity of several USPs, including USP52. | ||||||